| abstract |
The disclosure relates to compounds with the formula (III) wherein R5, R6, R7 are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds, as well as methods of use of the compounds for treatment of disorders associated with human hydroxysteroid dehydrogenase type 1 enzyme and for the preparation of a medicament which acts on the human 11-hydroxysteroid dehydrogenase type 1 enzyme. |